Committee for the Protection of Human Subjects

The Committee for the Protection of Human Subjects (CPHS) serves as the University of Oregon's Institutional Review Board (IRB). An IRB is an independent committee required under federal regulations to review and approve or disapprove, as well as monitor, research involving human participants. The mission of the CPHS/IRB is to protect the rights and welfare of par in University of Oregon research.

Submissions eligible for the Exempt or Expedited review process are reviewed on an ongoing basis throughout the year.
IRB Meeting Dates for Full Board Review
Note: The meeting dates below only apply to submissions requiring review by the fully convened IRB.
Meeting Date - Fall 2022

September 7, 2022

September 21, 2022

October 5, 2022

October 19, 2022

November 2, 2022

November 16, 2022

December 7, 2022

December 21, 2022

Meeting Date - Winter 2023

January 4, 2023

January 18, 2023

February 1, 2023

February 15, 2023

March 1, 2023

March 15, 2023

Meeting Date - Spring 2023

April 5, 2023

April 19, 2023

May 3, 2023

May 17, 2023

June 7, 2023

June 21, 2023

Meeting Date - Summer 2023

July 5, 2023

July 19, 2023

August 2, 2023

August 16, 2023

Meetings start at 8:30a.m. and are held remotely for the time being due to COVID-19. When in person meeting resume they are held at 677 East 12th Ave, Suite 500 in the main conference room (Mt. Hood - Room 506). 

Studies may be submitted at any time. Once a study is determined to require full board review and is ready for consideration by the fully convened IRB, the study is assigned to the next available committee meeting agenda.  

NOTE: Meetings will be canceled if there are no study submissions.

Committee Meeting Attendance

Frequently, the committee will request a representative of the research team attend the meeting in order to explain and/or clarify portions of the proposed research. In such instances, a Research Compliance Services (RCS) staff member will contact the investigator with the anticipated time the study will be considered.

The investigator in attendance should be prepared to provide a brief 2-3 minute overview of the proposed research focusing on the procedures involving human subjects, the risks, and the measures in place to mitigate the risks. The floor will then be opened up to members of the board to ask any immediate questions. Afterwards, the investigator will be excused for the final deliberation and vote. An RCS Staff member will contact the investigator by the end of the week to convey the meeting outcome.


If you have questions, please contact Research Compliance Services.